Mark Cobbold
Kala Pharmaceuticals (United States)
ORCID: 0000-0001-8931-4142Also affiliated with AstraZeneca (Netherlands), AstraZeneca (Singapore), AstraZeneca (Japan), AstraZeneca (United States)
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Papers
Driven by 7 papers. Top paper: “Upregulation of C/EBPα Inhibits Suppressive Activity of Myeloid Cells and Potentiates Antitumor Response in Mice and Patients with Cancer”.
Debashis Sarker, Vikash Reebye, Sheba Jarvis, Mikael H. Sodergren, Andrew V. Kossenkov +26 more
Qiqi Yang, Songfa Zhang, David G. Millar, Eric Alpert, Daniel Do +16 more
Aya Matsui, Hiroto Kikuchi, Sebastian Klein, Émilie Mamessier, Ivy X. Chen +21 more
Chuan Yan, David G. Millar, Qiqi Yang, James M. Heather, Adam Langenbucher +14 more
Matthew Spindler, Marta Herrero Alonso, Yifang Shui, David G. Millar, David S. Johnson +3 more
Dewald van Dyk, Christine Fazenbaker, Kelly McGlinchey, Weichuan Luo, Jessica Pezold +24 more
Jennifer G. Abelin, Stacy A. Malaker, Paisley T. Myers, Abu Z. Saeed, Lora Steadman +6 more